NASDAQ: BRNS
Barinthus Biotherapeutics PLC Stock Ownership - Who owns Barinthus Biotherapeutics?

Insider buying vs selling

Have Barinthus Biotherapeutics PLC insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when BRNS insiders and whales buy or sell their stock.

BRNS Shareholders

What type of owners hold Barinthus Biotherapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Oxford Sciences Innovation PLC21.81%8,797,770$7.94MInsider
Mg Investment Management Ltd15.27%6,160,946$5.56MInsider
Mg PLC12.88%5,197,349$4.69MInstitution
Mg Alternatives Investment Management Ltd10.19%4,108,752$3.71MInsider
William Enright4.40%1,773,300$1.60MInsider
Alphabet Inc3.75%1,513,644$1.37MInstitution
Hsg Holding Ltd3.52%1,420,473$1.28MInstitution
DC Funds LP1.59%642,204$579.91kInstitution
Geoffrey Lynn1.59%640,639$578.50kInsider
Gilead Sciences Inc0.92%369,855$333.98kInstitution

1 of 3

BRNS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BRNS23.51%54.05%
CLNN1.16%98.84%Net BuyingNet Selling
OKUR32.03%67.97%Net BuyingNet Selling
JUNS1.14%0.10%
ACRV60.12%39.88%Net SellingNet Selling

Barinthus Biotherapeutics Stock Ownership FAQ

Who owns Barinthus Biotherapeutics?

Barinthus Biotherapeutics (NASDAQ: BRNS) is owned by 23.51% institutional shareholders, 54.05% Barinthus Biotherapeutics insiders, and 22.44% retail investors. Oxford Sciences Innovation PLC is the largest individual Barinthus Biotherapeutics shareholder, owning 8.80M shares representing 21.81% of the company. Oxford Sciences Innovation PLC's Barinthus Biotherapeutics shares are currently valued at $7.94M.

If you're new to stock investing, here's how to buy Barinthus Biotherapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.